KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Total Non-Current Liabilities (2016 - 2025)

Rigel Pharmaceuticals (RIGL) has 16 years of Total Non-Current Liabilities data on record, last reported at $122.1 million in Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 21.56% year-over-year to $122.1 million; the TTM value through Dec 2025 reached $122.1 million, down 21.56%, while the annual FY2025 figure was $122.1 million, 21.56% down from the prior year.
  • Total Non-Current Liabilities reached $122.1 million in Q4 2025 per RIGL's latest filing, up from $117.4 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $155.7 million in Q4 2024 and bottomed at $80.2 million in Q1 2021.
  • Average Total Non-Current Liabilities over 5 years is $103.8 million, with a median of $105.7 million recorded in 2022.
  • Peak YoY movement for Total Non-Current Liabilities: skyrocketed 46.98% in 2024, then decreased 21.56% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $84.2 million in 2021, then rose by 25.41% to $105.6 million in 2022, then rose by 0.28% to $105.9 million in 2023, then surged by 46.98% to $155.7 million in 2024, then decreased by 21.56% to $122.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $122.1 million in Q4 2025, $117.4 million in Q1 2025, and $155.7 million in Q4 2024.